Loading…

Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults

The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods In this randomized, double-blind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 80...

Full description

Saved in:
Bibliographic Details
Published in:American journal of health-system pharmacy 2011-01, Vol.68 (1), p.47-51
Main Authors: Pavliv, Leo, Voss, Bryan, Rock, Amy
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33
cites cdi_FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33
container_end_page 51
container_issue 1
container_start_page 47
container_title American journal of health-system pharmacy
container_volume 68
creator Pavliv, Leo
Voss, Bryan
Rock, Amy
description The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods In this randomized, double-blind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 800 mg i.v. ibuprofen (infused over five to seven minutes) concomitantly with an oral placebo or 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection). After a six-day washout period, subjects received the treatment not previously received. Blood samples were taken 1 hour before each dose of study medication was administered and throughout the 12 hours thereafter. Plasma ibuprofen concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. The frequency and severity of treatment-emergent adverse effects were monitored throughout the study. The maximum plasma concentration (C(max)) of i.v. ibuprofen was approximately twice that of oral ibuprofen, and the (t(max)) of i.v. ibuprofen was 0.11 hour, compared with 1.5 hours for oral ibuprofen. However, the elimination half-life of i.v. and oral ibuprofen did not differ, both of which were approximately 2 hours. Oral ibuprofen was 100% bioavailable; therefore, the area under the concentration-time curve did not differ between i.v. and oral ibuprofen. In addition, i.v. ibuprofen infused over five to seven minutes did not differ in terms of safety or tolerability when compared with oral ibuprofen. I.V. ibuprofen, when administered over five to seven minutes in healthy subjects, achieved a higher C(max) and a more-rapid t(max) than did oral ibuprofen and was found to be safe and well tolerated.
doi_str_mv 10.2146/ajhp100120
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_818644592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A249137908</galeid><sourcerecordid>A249137908</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33</originalsourceid><addsrcrecordid>eNptkU1rHDEMhk1IaZJtL_kBxZBDIGS2tufDnuMSkrYQSA7JeZA9ctfJzHhrewL77-tlNy2FooPEq0dC4iXknLOl4FXzFV7WG84YF-yInPK6rAvRMnacaybbQjAlTshZjC87RLHmIzkRnDcVa-pToh_XEEYw_tVNmJyJ1zSCxbS9pjD1NPkBA2g3uLSl3lKgATaup26yc3R-2mlu-bakTs-b4C1OuUXXCENabyn085DiJ_LBwhDx8yEvyPPd7dPN9-L-4duPm9V9Ycq6TEWtUFhoeglcWmVAGGZAKWXyjyCl4Fa2AnrFdV0ZYGgbbXSvlZbCyArLckEu93vzIb9mjKkbXTQ4DDChn2OnuGqqqm5FJi_25E8YsMu_-BTA7OhuJaqWl7JlKlPL_1A5ehyd8RNal_V_Bq72Ayb4GAPabhPcCGHbcdbtnOr-OpXhL4drZz1i_wd9t6b8Dbx2jiM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>818644592</pqid></control><display><type>article</type><title>Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults</title><source>Oxford Journals Online</source><creator>Pavliv, Leo ; Voss, Bryan ; Rock, Amy</creator><creatorcontrib>Pavliv, Leo ; Voss, Bryan ; Rock, Amy</creatorcontrib><description>The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods In this randomized, double-blind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 800 mg i.v. ibuprofen (infused over five to seven minutes) concomitantly with an oral placebo or 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection). After a six-day washout period, subjects received the treatment not previously received. Blood samples were taken 1 hour before each dose of study medication was administered and throughout the 12 hours thereafter. Plasma ibuprofen concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. The frequency and severity of treatment-emergent adverse effects were monitored throughout the study. The maximum plasma concentration (C(max)) of i.v. ibuprofen was approximately twice that of oral ibuprofen, and the (t(max)) of i.v. ibuprofen was 0.11 hour, compared with 1.5 hours for oral ibuprofen. However, the elimination half-life of i.v. and oral ibuprofen did not differ, both of which were approximately 2 hours. Oral ibuprofen was 100% bioavailable; therefore, the area under the concentration-time curve did not differ between i.v. and oral ibuprofen. In addition, i.v. ibuprofen infused over five to seven minutes did not differ in terms of safety or tolerability when compared with oral ibuprofen. I.V. ibuprofen, when administered over five to seven minutes in healthy subjects, achieved a higher C(max) and a more-rapid t(max) than did oral ibuprofen and was found to be safe and well tolerated.</description><identifier>ISSN: 1079-2082</identifier><identifier>EISSN: 1535-2900</identifier><identifier>DOI: 10.2146/ajhp100120</identifier><identifier>PMID: 21164065</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Administration, Oral ; Adult ; Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage ; Anti-Inflammatory Agents, Non-Steroidal - adverse effects ; Anti-Inflammatory Agents, Non-Steroidal - blood ; Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics ; Cross-Over Studies ; Dosage and administration ; Double-Blind Method ; Drug tolerance ; Female ; Gas Chromatography-Mass Spectrometry ; Half-Life ; Humans ; Ibuprofen ; Ibuprofen - administration &amp; dosage ; Ibuprofen - adverse effects ; Ibuprofen - blood ; Ibuprofen - pharmacokinetics ; Infusions, Intravenous ; Male ; Pharmacokinetics</subject><ispartof>American journal of health-system pharmacy, 2011-01, Vol.68 (1), p.47-51</ispartof><rights>COPYRIGHT 2011 Oxford University Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33</citedby><cites>FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21164065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pavliv, Leo</creatorcontrib><creatorcontrib>Voss, Bryan</creatorcontrib><creatorcontrib>Rock, Amy</creatorcontrib><title>Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults</title><title>American journal of health-system pharmacy</title><addtitle>Am J Health Syst Pharm</addtitle><description>The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods In this randomized, double-blind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 800 mg i.v. ibuprofen (infused over five to seven minutes) concomitantly with an oral placebo or 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection). After a six-day washout period, subjects received the treatment not previously received. Blood samples were taken 1 hour before each dose of study medication was administered and throughout the 12 hours thereafter. Plasma ibuprofen concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. The frequency and severity of treatment-emergent adverse effects were monitored throughout the study. The maximum plasma concentration (C(max)) of i.v. ibuprofen was approximately twice that of oral ibuprofen, and the (t(max)) of i.v. ibuprofen was 0.11 hour, compared with 1.5 hours for oral ibuprofen. However, the elimination half-life of i.v. and oral ibuprofen did not differ, both of which were approximately 2 hours. Oral ibuprofen was 100% bioavailable; therefore, the area under the concentration-time curve did not differ between i.v. and oral ibuprofen. In addition, i.v. ibuprofen infused over five to seven minutes did not differ in terms of safety or tolerability when compared with oral ibuprofen. I.V. ibuprofen, when administered over five to seven minutes in healthy subjects, achieved a higher C(max) and a more-rapid t(max) than did oral ibuprofen and was found to be safe and well tolerated.</description><subject>Administration, Oral</subject><subject>Adult</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - blood</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</subject><subject>Cross-Over Studies</subject><subject>Dosage and administration</subject><subject>Double-Blind Method</subject><subject>Drug tolerance</subject><subject>Female</subject><subject>Gas Chromatography-Mass Spectrometry</subject><subject>Half-Life</subject><subject>Humans</subject><subject>Ibuprofen</subject><subject>Ibuprofen - administration &amp; dosage</subject><subject>Ibuprofen - adverse effects</subject><subject>Ibuprofen - blood</subject><subject>Ibuprofen - pharmacokinetics</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Pharmacokinetics</subject><issn>1079-2082</issn><issn>1535-2900</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNptkU1rHDEMhk1IaZJtL_kBxZBDIGS2tufDnuMSkrYQSA7JeZA9ctfJzHhrewL77-tlNy2FooPEq0dC4iXknLOl4FXzFV7WG84YF-yInPK6rAvRMnacaybbQjAlTshZjC87RLHmIzkRnDcVa-pToh_XEEYw_tVNmJyJ1zSCxbS9pjD1NPkBA2g3uLSl3lKgATaup26yc3R-2mlu-bakTs-b4C1OuUXXCENabyn085DiJ_LBwhDx8yEvyPPd7dPN9-L-4duPm9V9Ycq6TEWtUFhoeglcWmVAGGZAKWXyjyCl4Fa2AnrFdV0ZYGgbbXSvlZbCyArLckEu93vzIb9mjKkbXTQ4DDChn2OnuGqqqm5FJi_25E8YsMu_-BTA7OhuJaqWl7JlKlPL_1A5ehyd8RNal_V_Bq72Ayb4GAPabhPcCGHbcdbtnOr-OpXhL4drZz1i_wd9t6b8Dbx2jiM</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Pavliv, Leo</creator><creator>Voss, Bryan</creator><creator>Rock, Amy</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110101</creationdate><title>Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults</title><author>Pavliv, Leo ; Voss, Bryan ; Rock, Amy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - blood</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</topic><topic>Cross-Over Studies</topic><topic>Dosage and administration</topic><topic>Double-Blind Method</topic><topic>Drug tolerance</topic><topic>Female</topic><topic>Gas Chromatography-Mass Spectrometry</topic><topic>Half-Life</topic><topic>Humans</topic><topic>Ibuprofen</topic><topic>Ibuprofen - administration &amp; dosage</topic><topic>Ibuprofen - adverse effects</topic><topic>Ibuprofen - blood</topic><topic>Ibuprofen - pharmacokinetics</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pavliv, Leo</creatorcontrib><creatorcontrib>Voss, Bryan</creatorcontrib><creatorcontrib>Rock, Amy</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of health-system pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pavliv, Leo</au><au>Voss, Bryan</au><au>Rock, Amy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults</atitle><jtitle>American journal of health-system pharmacy</jtitle><addtitle>Am J Health Syst Pharm</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>68</volume><issue>1</issue><spage>47</spage><epage>51</epage><pages>47-51</pages><issn>1079-2082</issn><eissn>1535-2900</eissn><abstract>The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods In this randomized, double-blind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 800 mg i.v. ibuprofen (infused over five to seven minutes) concomitantly with an oral placebo or 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection). After a six-day washout period, subjects received the treatment not previously received. Blood samples were taken 1 hour before each dose of study medication was administered and throughout the 12 hours thereafter. Plasma ibuprofen concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. The frequency and severity of treatment-emergent adverse effects were monitored throughout the study. The maximum plasma concentration (C(max)) of i.v. ibuprofen was approximately twice that of oral ibuprofen, and the (t(max)) of i.v. ibuprofen was 0.11 hour, compared with 1.5 hours for oral ibuprofen. However, the elimination half-life of i.v. and oral ibuprofen did not differ, both of which were approximately 2 hours. Oral ibuprofen was 100% bioavailable; therefore, the area under the concentration-time curve did not differ between i.v. and oral ibuprofen. In addition, i.v. ibuprofen infused over five to seven minutes did not differ in terms of safety or tolerability when compared with oral ibuprofen. I.V. ibuprofen, when administered over five to seven minutes in healthy subjects, achieved a higher C(max) and a more-rapid t(max) than did oral ibuprofen and was found to be safe and well tolerated.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>21164065</pmid><doi>10.2146/ajhp100120</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1079-2082
ispartof American journal of health-system pharmacy, 2011-01, Vol.68 (1), p.47-51
issn 1079-2082
1535-2900
language eng
recordid cdi_proquest_miscellaneous_818644592
source Oxford Journals Online
subjects Administration, Oral
Adult
Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
Anti-Inflammatory Agents, Non-Steroidal - adverse effects
Anti-Inflammatory Agents, Non-Steroidal - blood
Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics
Cross-Over Studies
Dosage and administration
Double-Blind Method
Drug tolerance
Female
Gas Chromatography-Mass Spectrometry
Half-Life
Humans
Ibuprofen
Ibuprofen - administration & dosage
Ibuprofen - adverse effects
Ibuprofen - blood
Ibuprofen - pharmacokinetics
Infusions, Intravenous
Male
Pharmacokinetics
title Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A19%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics,%20safety,%20and%20tolerability%20of%20a%20rapid%20infusion%20of%20i.v.%20ibuprofen%20in%20healthy%20adults&rft.jtitle=American%20journal%20of%20health-system%20pharmacy&rft.au=Pavliv,%20Leo&rft.date=2011-01-01&rft.volume=68&rft.issue=1&rft.spage=47&rft.epage=51&rft.pages=47-51&rft.issn=1079-2082&rft.eissn=1535-2900&rft_id=info:doi/10.2146/ajhp100120&rft_dat=%3Cgale_proqu%3EA249137908%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=818644592&rft_id=info:pmid/21164065&rft_galeid=A249137908&rfr_iscdi=true